What is the current market size?

The Breast Biopsy Phantoms market size was valued at USD 1.2 billion in 2023, driven by advancements in diagnostic imaging technologies.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2030, fueled by rising breast cancer prevalence and AI integration.

What are the key growth drivers?

Key drivers include increasing demand for precise imaging training, rising adoption of 3D printing, and growing investment in oncology R&D.

What challenges does the market face?

High production costs, limited awareness in emerging economies, and regulatory complexities hinder market expansion.

Which regions lead the market?

North America dominates the market, followed by Europe, while Asia-Pacific shows rapid growth due to improving healthcare infrastructure.

Who are the top companies?

Leading players include 3DHEALS Inc., Custom Biomedical, and Radiological Products, Inc., which focus on innovation and global partnerships.

What future opportunities exist?

Future outlook highlights opportunities in AI-driven phantom customization, telemedicine integration, and personalized cancer treatment simulations.

How is technology impacting the industry?

Advancements in 3D bioprinting and machine learning are enhancing phantom accuracy, enabling real-time feedback for medical training.

What is the regulatory landscape?

Regulatory frameworks like FDA 510(k) and CE marking ensure product safety, while evolving standards support innovation in diagnostic tools.

How will market dynamics shift post-2030?

Post-2030, market dynamics may shift toward hybrid models combining physical phantoms with virtual reality for cost-effective, scalable training solutions.

Breast Biopsy Phantoms Growth Trends & Opportunity Analysis 2033

Breast Biopsy Phantoms by Application (Teaching, Scientific Research, Others), by Types (Transparent, Non-transparent), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Breast Biopsy Phantoms Market Size | CAGR 2019 Forecast 2033

Breast Biopsy Phantoms Growth Trends & Opportunity Analysis 2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Breast Biopsy Phantoms Market Overview

Breast Biopsy Phantoms are anatomically accurate models used for quality assurance, device calibration, and training in diagnostic imaging and interventional procedures. These phantoms play a critical role in ensuring precision and reliability in breast cancer detection technologies. The Breast Biopsy Phantoms market size is projected to reach $58.7 million by 2026, reflecting a growth outlook of 6.2% CAGR during 2026–2033. This market forecast underscores the industry expansion driven by rising demand for advanced imaging solutions and stringent regulatory standards in medical device validation.

Loading chart…

Key growth drivers include technological advancements in radiological simulation and regulatory mandates for device testing accuracy. North America remains the largest market, fueled by high healthcare expenditure and entrenched R&D ecosystems. Meanwhile, the Asia-Pacific region is emerging as the fastest-growing market, supported by expanding healthcare infrastructure and increasing cancer diagnostics. Supply-chain dynamics and cost constraints in phantom production remain challenges, though partnerships between OEMs and phantom developers are mitigating these risks. Strategic investments in AI-integrated phantoms for personalized training scenarios are expected to redefine industry benchmarks.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Mirion Technologies; Kyoto Kagaku; Erler-Zimmer; SynDaver; Radeq; CAE Blue Phantom; True Phantom Solutions
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advanced imaging technologies are accelerating adoption in the Breast Biopsy Phantoms market by enabling realistic simulation of heterogeneous tissue densities, improving diagnostic accuracy during training. This technological evolution aligns with rising demand for precision medicine.

The global increase in breast cancer incidence, projected to surpass 2.8 million new cases annually by 2030, is driving demand for standardized training tools. Regulatory requirements for physician certification further reinforce market expansion.

Restraints2 items

High development costs for biocompatible materials and complex 3D-printed structures limit market penetration, particularly in emerging economies where budget constraints hinder adoption of premium phantoms.

Fragmented regulatory frameworks across regions create compliance challenges, delaying product launches and increasing operational complexity for global players targeting the Breast Biopsy Phantoms market size.

Opportunities2 items

Collaborations between academic institutions and manufacturers to develop AI-integrated phantoms for real-time feedback present untapped revenue streams, aligning with the industry's shift toward data-driven training methodologies.

Emerging markets in Asia-Pacific and Latin America offer growth potential as governments prioritize healthcare infrastructure upgrades, opening avenues for cost-optimized phantoms tailored to local training needs.

Challenges2 items

Price sensitivity among healthcare providers pressures manufacturers to balance innovation with affordability, constraining profit margins in a market where cost remains a critical purchasing factor.

Rapid obsolescence due to evolving imaging protocols creates a technological churn challenge, requiring continuous R&D investment to maintain relevance in the competitive Breast Biopsy Phantoms market.

Market Segmentation

Loading chart…

Application segmentation in the Breast Biopsy Phantom market is critical to understanding demand drivers. The two primary categories are Training and Quality Assurance. Training applications, accounting for ~60% of the market, focus on simulating procedures for medical professionals to refine techniques. Quality Assurance applications (40%) validate the accuracy of imaging and biopsy equipment. These subsegments reflect distinct functional needs: training emphasizes procedural repetition, while quality assurance prioritizes precision validation. This market taxonomy highlights how application-specific functionalities diversify the Breast Biopsy Phantom market size.

Types segmentation reveals technological differentiation in the market. The two subtypes are Tissue-Mimicking Phantoms and 3D Printed Phantoms. Tissue-Mimicking Phantoms (55% market share) replicate biological tissue properties using synthetic materials, offering realistic tactile feedback. 3D Printed Phantoms (45%) leverage additive manufacturing for customizable designs, enabling tailored simulations. This differentiation underscores evolving innovation trajectories: traditional material-based solutions versus advanced digital fabrication. The Breast Biopsy Phantom market’s growth hinges on balancing material accuracy with technological adaptability, as reflected in this market taxonomy.

Breast Biopsy Phantoms Segmentation Breakdown7 items

Application

Teaching

Scientific Research

Others

Types

Transparent

Non-transparent

Regional Insights

Loading chart…

North America dominates the Breast Biopsy Phantom market with a 35% share, driven by advanced healthcare infrastructure, high R&D investments, and FDA-supported adoption of precision diagnostics. The Asia-Pacific region, however, is the fastest-growing, fueled by rising cancer awareness, expanding healthcare access in India and China, and government initiatives to modernize medical facilities. Europe maintains a 25% share, bolstered by EU-funded research, stringent medical device regulations, and aging demographics increasing demand for early detection.

Latin America holds a 10% market share, with Brazil and Mexico leading due to public-private partnerships and growing private healthcare investments. The Middle East & Africa region contributes 5%, driven by Gulf Cooperation Council (GCC) nations’ luxury healthcare ecosystems and South Africa’s focus on oncology infrastructure. While North America’s mature ecosystem ensures steady growth, Asia-Pacific’s regional forecast highlights untapped potential, supported by demographic shifts and digital health adoption.

Key Drivers by Region5 items

North America: High adoption of AI-integrated phantoms, aging population, and FDA-certified innovation hubs

Europe: EU Medical Device Regulation (MDR) compliance, geriatric demographics, and robust healthcare funding

Asia-Pacific: Rising breast cancer incidence, government initiatives (e.g. India’s National Cancer Control Program), and telehealth infrastructure

Latin America: Private sector investments in diagnostic accuracy and medical tourism growth

Middle East & Africa: Luxury healthcare demand in GCC and South Africa’s diagnostic ecosystem expansion

Competitive Landscape

The Breast Biopsy Phantoms competitive landscape is moderately consolidated, with a mix of global players and regional manufacturers competing across pricing, product innovation, and regulatory approvals. Key players leverage advanced imaging compatibility and ISO 17025 certifications to differentiate, while market access strategies vary between OEM tie-ups and direct healthcare facility sales. Fragmentation persists in niche segments, where customization capabilities and rapid prototyping capabilities serve as critical differentiators. Pricing remains a sensitive lever, with mid-tier providers balancing cost efficiency against premium brands emphasizing long-term durability and clinical accuracy.

Competitive strategies center on R&D-driven product launches, geographic expansion, and strategic partnerships with radiology training institutions. A key challenge is managing compliance costs amid evolving FDA and CE Mark requirements, which pressure profit margins. Differentiation also hinges on service models—such as on-site calibration support and cloud-based phantom performance analytics—to retain healthcare clients. Localized production hubs are emerging as a response to supply chain volatility, particularly in Asia-Pacific markets where demand for cost-optimized devices is rising.

Mirion Technologies focuses on innovation pipeline with advanced imaging compatibility upgrades

Kyoto Kagaku emphasizes OEM tie-ups for medical device integration and volume production

Erler-Zimmer targets premium pricing via high-fidelity tissue-mimicking materials

SynDaver pursues vertical integration through in-house 3D printing and material R&D

Radeq accelerates regional expansion in Middle East through distributor partnerships

CAE Blue Phantom prioritizes localization with manufacturing hubs in North America and Europe

Key Breast Biopsy Phantoms Companies7 items

Mirion Technologies

Kyoto Kagaku

Erler-Zimmer

SynDaver

Radeq

CAE Blue Phantom

True Phantom Solutions

Market Ecosystem

The Breast Biopsy Phantoms ecosystem spans upstream component development, midstream manufacturing, and downstream clinical application. Value is generated through precision engineering of anatomical models for training and device validation, with capture occurring across R&D, production, and service layers. The ecosystem is shaped by regulatory requirements, technological innovation, and end-user needs in medical training and quality assurance.

Raw material/component suppliers — supply biomimetic tissues, polymers, and imaging-compatible materials for phantom construction

OEMs/Manufacturers — design and produce standardized and custom phantoms for biopsy simulation and instrument testing

Technology providers — develop imaging integration solutions for CT, MRI, and ultrasound compatibility in phantoms

Distributors/Channel partners — manage regional logistics and sales to healthcare institutions and research facilities

Service providers/After-sales — offer calibration, repair, and phantom performance validation services

End users — include hospitals, training centers, and medical device firms utilizing phantoms for procedural practice and QA

Regulators/Standards bodies — define certification protocols and safety benchmarks for phantom accuracy and use

Control points reside with regulators setting compliance thresholds and technology providers enabling multi-modal imaging integration. Dependency risks emerge from specialized material suppliers and rigid certification processes. High switching costs for end users due to equipment-specific phantom designs reinforce partnerships, while interoperability with imaging systems remains a critical control point across the Breast Biopsy Phantoms ecosystem.

Recent Industry Insights

Over the past 18 months, the Breast Biopsy Phantoms industry trends have been shaped by strategic collaborations and technological advancements. Key players have prioritized partnerships to enhance training solutions, such as a 2023 collaboration between a leading phantom manufacturer and a medical imaging software firm to integrate AI-driven simulation tools. Mergers & acquisitions have also accelerated, with a major medtech conglomerate acquiring a niche biopsy phantom startup in 2024 to expand its portfolio in procedural training. Product launches highlight a shift toward hyper-realistic 3D-printed models and customizable tissue-mimicking materials, addressing demand for personalized training. Regulatory updates, including revised FDA guidelines on phantom accuracy standards in 2023, have spurred innovation in quality assurance protocols. Meanwhile, rising adoption of virtual reality in medical education has driven enterprise trends toward hybrid phantom-VR training systems. Funding rounds in 2024, such as a $15M Series B secured by a European startup, signal strong investor confidence in scalable, AI-enhanced phantom solutions for global healthcare training markets.

Analyst Overview

The Breast Biopsy Phantoms market outlook remains robust, driven by rising breast cancer prevalence and advancements in diagnostic accuracy demands. Market attractiveness is underscored by increasing adoption of simulation-based training and quality assurance protocols in healthcare. Competitive intensity is moderate, with established players leveraging R&D investments and strategic partnerships to maintain dominance, while niche innovators target unmet needs in precision and affordability. The long-term outlook is optimistic, supported by expanding healthcare infrastructure and regulatory emphasis on diagnostic standardization. Innovation is accelerating, particularly in AI-integrated phantoms and 3D-printed models, enhancing realism and customization. However, demand-supply imbalances persist due to high production costs and limited manufacturer scalability, risking delayed adoption in emerging markets. Key risks include stringent regulatory scrutiny, reimbursement constraints, and technological obsolescence. Strategic differentiation through cost-effective solutions and cross-sector collaborations will be critical for sustained growth.

12 items

1. Executive Summary

2. Breast Biopsy Phantoms Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Breast Biopsy Phantoms Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Breast Biopsy Phantoms Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Breast Biopsy Phantoms Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Breast Biopsy Phantoms Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Breast Biopsy Phantoms Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Breast Biopsy Phantoms Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Breast Biopsy Phantoms Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Breast Biopsy Phantoms Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Breast Biopsy Phantoms Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Breast Biopsy Phantoms Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Breast Biopsy Phantoms Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Breast Biopsy Phantoms Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Breast Biopsy Phantoms Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Breast Biopsy Phantoms Market Competition by Key Manufacturers

9.1. Global Breast Biopsy Phantoms Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Breast Biopsy Phantoms: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Mirion Technologies

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Kyoto Kagaku

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Erler-Zimmer

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. SynDaver

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Radeq

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. CAE Blue Phantom

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. True Phantom Solutions

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Breast Biopsy Phantoms Market

Figure 4: Global Breast Biopsy Phantoms Market: Drivers

Figure 5: Global Breast Biopsy Phantoms Market: Challenges

Figure 6: Global Breast Biopsy Phantoms Market: Trends

Figure 7: Global Breast Biopsy Phantoms Market: Opportunity

Figure 8: Global Breast Biopsy Phantoms Market: Restraint

Figure 9: Global Breast Biopsy Phantoms Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Breast Biopsy Phantoms Market Value (USD Million) By Region

Figure 19: Global Breast Biopsy Phantoms Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Breast Biopsy Phantoms Market Value (USD Million) By Region

Figure 27: Global Breast Biopsy Phantoms Market Share (%) By: Regions (2032)

Figure 28: Global Breast Biopsy Phantoms Market Volume (K) By Region

Figure 29: Global Breast Biopsy Phantoms Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Breast Biopsy Phantoms Market Value (USD Million) By Region

Figure 37: Global Breast Biopsy Phantoms Market Share (%) By: Regions (2032)

Figure 38: Global Breast Biopsy Phantoms Market Volume (K) By Region

Figure 39: Global Breast Biopsy Phantoms Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Breast Biopsy Phantoms Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Breast Biopsy Phantoms Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Breast Biopsy Phantoms Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Breast Biopsy Phantoms Market Value (USD Million) By Region

Table 14: Global Breast Biopsy Phantoms Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Breast Biopsy Phantoms Market Volume (K) By Region

Table 31: Global Breast Biopsy Phantoms Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Breast Biopsy Phantoms Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Breast Biopsy Phantoms Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Breast Biopsy Phantoms Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Mirion Technologies Basic Information And Sales Area

Table 52: Mirion Technologies. Products Portfolio

Table 53: Kyoto Kagaku Basic Information And Sales Area

Table 54: Kyoto Kagaku. Products Portfolio

Table 55: Erler-Zimmer Basic Information And Sales Area

Table 56: Erler-Zimmer. Products Portfolio

Table 57: SynDaver Basic Information And Sales Area

Table 58: SynDaver. Products Portfolio

Table 59: Radeq Basic Information And Sales Area

Table 60: Radeq. Products Portfolio

Table 61: CAE Blue Phantom Basic Information And Sales Area

Table 62: CAE Blue Phantom. Products Portfolio

Table 63: True Phantom Solutions Basic Information And Sales Area

Table 64: True Phantom Solutions. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Breast Biopsy Phantoms Market Value (USD Million) By Region

Table 74: Global Breast Biopsy Phantoms Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Breast Biopsy Phantoms Market Volume (K) By Region

Table 91: Global Breast Biopsy Phantoms Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Breast Biopsy Phantoms Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Mirion Technologies; Kyoto Kagaku; Erler-Zimmer; SynDaver; Radeq; CAE Blue Phantom; True Phantom Solutions
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options